tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ATR Stock Latest News

AptarGroup Earnings Call: Pharma and Closures Shine
Company AnnouncementsAptarGroup Earnings Call: Pharma and Closures Shine
1h ago
ATR
AptarGroup’s Consistent Financial Strength and Pharma Segment Growth Drive Buy Rating
PremiumRatings
AptarGroup’s Consistent Financial Strength and Pharma Segment Growth Drive Buy Rating
1d ago
ATR
AptarGroup reports Q2 EPS $1.67, consensus $1.59
PremiumThe Fly
AptarGroup reports Q2 EPS $1.67, consensus $1.59
1d ago
ATR
AptarGroup sees Q3 EPS $1.53-$1.61, consensus $1.65
PremiumThe Fly
AptarGroup sees Q3 EPS $1.53-$1.61, consensus $1.65
1d ago
ATR
Is ATR a Buy, Before Earnings?
PremiumPre-Earnings
Is ATR a Buy, Before Earnings?
4d ago
ATR
AptarGroup price target raised to $173 from $170 at Wells Fargo
PremiumThe FlyAptarGroup price target raised to $173 from $170 at Wells Fargo
15d ago
ATR
AptarGroup acquires Mod3 Pharma’s clinical trial manufacturing capabilities
Premium
The Fly
AptarGroup acquires Mod3 Pharma’s clinical trial manufacturing capabilities
17d ago
ATR
SWKH
AptarGroup debuts dual-active technology to control moisture, oxygen
Premium
The Fly
AptarGroup debuts dual-active technology to control moisture, oxygen
24d ago
ATR
AptarGroup price target raised to $170 from $162 at Wells Fargo
PremiumThe Fly
AptarGroup price target raised to $170 from $162 at Wells Fargo
3M ago
ATR
AptarGroup’s Strong Pharmaceutical Growth and Strategic Initiatives Drive Buy Rating
PremiumRatings
AptarGroup’s Strong Pharmaceutical Growth and Strategic Initiatives Drive Buy Rating
3M ago
ATR
AptarGroup’s Q1 2025 Results: Sales Dip, Pharma Grows
PremiumCompany Announcements
AptarGroup’s Q1 2025 Results: Sales Dip, Pharma Grows
3M ago
ATR
AptarGroup’s Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
AptarGroup’s Earnings Call: Growth Amid Challenges
3M ago
ATR
AptarGroup’s Mixed Segment Performance and Economic Pressures Lead to Hold Rating
PremiumRatingsAptarGroup’s Mixed Segment Performance and Economic Pressures Lead to Hold Rating
3M ago
ATR
AptarGroup reports Q1 adjusted EPS $1.20, consensus $1.15
Premium
The Fly
AptarGroup reports Q1 adjusted EPS $1.20, consensus $1.15
3M ago
ATR
AptarGroup sees Q2 EPS $1.56-$1.64, consensus $1.41
Premium
The Fly
AptarGroup sees Q2 EPS $1.56-$1.64, consensus $1.41
3M ago
ATR
ATR Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ATR Upcoming Earnings Report: What to Expect?
3M ago
ATR
AptarGroup price target lowered to $175 from $190 at Raymond James
PremiumThe Fly
AptarGroup price target lowered to $175 from $190 at Raymond James
3M ago
ATR
AptarGroup commences clinical study to validate SmartTrack platform
PremiumThe Fly
AptarGroup commences clinical study to validate SmartTrack platform
4M ago
ATR
AptarGroup’s Hold Rating: Balancing Growth Prospects with Market and Internal Challenges
PremiumRatings
AptarGroup’s Hold Rating: Balancing Growth Prospects with Market and Internal Challenges
5M ago
ATR
AptarGroup’s Strong Pharma Performance and Strategic Expansion Justify Buy Rating
PremiumRatingsAptarGroup’s Strong Pharma Performance and Strategic Expansion Justify Buy Rating
5M ago
ATR
AptarGroup: Strong Q4 Performance and Promising Long-Term Outlook Support Buy Rating
Premium
Ratings
AptarGroup: Strong Q4 Performance and Promising Long-Term Outlook Support Buy Rating
6M ago
ATR
AptarGroup price target lowered to $160 from $185 at Baird
Premium
The Fly
AptarGroup price target lowered to $160 from $185 at Baird
6M ago
ATR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >